Nevro Corp
NVRODelisted Apr 3, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001444380
Nevro Corp was delisted on Apr 3, 2025; its insiders filed their last Form 4 on Apr 3, 2025; 127 institutions reported holding it in 13F filings for Q1 2025, worth $197.5M in total; no superinvestor held it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 1:10 PM ET
Revenue flow, FY2024
Where the revenue went in FY2024, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2024: $113.4M (27.8% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 14, 2025 | Jan 9, 2024 | Jan 9, 2023 | Jan 10, 2022 | Jan 11, 2021 |
| Revenue | $408.5M | $425.2M | $406.4M | $386.9M | $362.0M |
| Cost of revenue | $139.0M | $135.1M | $130.0M | $120.9M | $112.1M |
| Gross profit | $269.5M | $290.1M | $276.4M | $266.0M | $249.9M |
| Operating expenses | $395.8M | $389.4M | $270.2M | $377.0M | $312.8M |
| Research and development | $51.5M | $54.4M | $53.1M | $47.7M | $45.6M |
| Selling, general and administrative | $309.8M | $334.7M | $322.1M | $309.3M | $267.2M |
| Operating income | -$126.2M | -$99.3M | $6.16M | -$110.9M | -$62.9M |
| Interest expense | – | $8.01M | $6.43M | $19.7M | $21.8M |
| Income tax | $1.09M | -$5.65M | $1.26M | $534.0K | $868.0K |
| Net income | -$113.4M | -$92.2M | $3.00M | -$131.4M | -$83.1M |
| EPS, basic | $-3.06 | $-2.56 | $0.08 | – | – |
| EPS, diluted | $-3.06 | $-2.56 | $0.08 | – | – |
| Weighted shares, basic | 37.1M | 36.0M | 35.3M | – | – |
| Weighted shares, diluted | 37.1M | 36.0M | 35.5M | – | – |
| Margins and growth | |||||
| Gross margin | 66.0% | 68.2% | 68.0% | 68.8% | 69.0% |
| Operating margin | -30.9% | -23.4% | 1.5% | -28.7% | -17.4% |
| Net margin | -27.8% | -21.7% | 0.7% | -34.0% | -22.9% |
| Revenue growth, year over year | −3.9% | +4.6% | +5.0% | +6.9% | −7.2% |
| Net income growth, year over year | – | −3,172.7% | – | – | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 14, 2025 | Jan 9, 2024 | Jan 9, 2023 | Jan 10, 2022 | Jan 11, 2021 |
| Cash and equivalents | $94.5M | $104.2M | $120.4M | $34.7M | $44.6M |
| Accounts receivable | $71.9M | $79.4M | $78.9M | $70.5M | $77.7M |
| Inventory | $103.3M | $118.7M | $99.6M | $93.5M | $83.3M |
| Total current assets | $476.0M | $530.9M | $562.9M | $531.2M | $753.1M |
| Property, plant and equipment | $26.6M | $24.6M | $22.3M | $20.7M | $13.5M |
| Goodwill | $0 | $38.2M | – | – | – |
| Intangible assets | $24.4M | $27.4M | – | – | – |
| Total assets | $553.8M | $635.7M | $602.4M | $574.5M | $789.4M |
| Accounts payable | $24.5M | $22.5M | $26.8M | $32.0M | $23.1M |
| Short-term debt | $38.0M | – | – | – | $168.8M |
| Total current liabilities | $102.9M | $83.4M | $79.2M | $82.2M | $239.2M |
| Long-term debt | $187.7M | $211.5M | $186.9M | $151.3M | $141.8M |
| Total liabilities | $322.8M | $342.6M | $278.5M | $270.9M | $401.0M |
| Shareholders' equity | $231.0M | $293.1M | $323.9M | $303.6M | $388.5M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 14, 2025 | Jan 9, 2024 | Jan 9, 2023 | Jan 10, 2022 | Jan 11, 2021 |
| Operating cash flow | -$19.4M | -$58.8M | $24.7M | -$41.9M | $1.19M |
| Capital expenditures | $9.79M | $8.59M | $7.54M | $12.3M | $6.03M |
| Free cash flow | -$29.2M | -$67.4M | $17.1M | -$54.2M | -$4.83M |
| Depreciation and amortization | $7.95M | $6.80M | $6.18M | $4.88M | $4.79M |
| Stock-based compensation | $51.2M | $56.9M | $56.8M | $44.4M | $42.7M |
| Investing cash flow | $14.6M | -$7.20M | $64.3M | $201.7M | -$369.9M |
| Financing cash flow | -$4.21M | $49.5M | -$2.46M | -$169.4M | $346.9M |
| Net change in cash | -$9.77M | -$16.2M | $85.7M | -$9.89M | -$21.1M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 12.5% | 13.4% | 14.0% | 11.5% | 11.8% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.